Autonomic innervation in multiple system atrophy and pure autonomic failure

Department of Neurological Sciences, University of Bologna, Bologna, Italy.
Journal of neurology, neurosurgery, and psychiatry (Impact Factor: 5.58). 12/2010; 81(12):1327-35. DOI: 10.1136/jnnp.2009.198135
Source: PubMed

ABSTRACT Pure autonomic failure (PAF) and multiple system atrophy (MSA) are both characterised by chronic dysautonomia although presenting different disability and prognosis. Skin autonomic function evaluation by indirect tests has revealed conflicting results in these disorders. Here, the authors report the first direct analysis of skin sympathetic fibres including structure and function in PAF and MSA to ascertain different underlying autonomic lesion sites which may help differentiate between the two conditions.
The authors studied eight patients with probable MSA (mean age 60±5 years) and nine patients fulfilling diagnostic criteria for PAF (64±8 years). They underwent head-up tilt test (HUTT), extensive microneurographic search for muscle and skin sympathetic nerve activities from peroneal nerve and punch skin biopsies from finger, thigh and leg to evaluate cholinergic and adrenergic autonomic dermal annexes innervation graded by a semiquantitative score presenting a high level of reliability.
MSA and PAF patients presented a comparable neurogenic orthostatic hypotension during HUTT and high failure rate of microneurographic trials to record sympathetic nerve activity, suggesting a similar extent of chronic dysautonomia. In contrast, they presented different skin autonomic innervation in the immunofluorescence analysis. MSA patients showed a generally preserved skin autonomic innervation with a significantly higher score than PAF patients showing a marked postganglionic sympathetic denervation. In MSA patients with a long disease duration, morphological abnormalities and/or a slightly decreased autonomic score could be found in the leg reflecting a mild postganglionic involvement.
Autonomic innervation study of skin annexes is a reliable method which may help differentiate MSA from PAF.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Microneurography is a unique neurophysiological technique that allows recordings from unmyelinated postganglionic sympathetic or afferent nociceptive fibers.•In recent years, microneurography has been widely used to explore central and peripheral neurological disorders to ascertain the underlying autonomic impairments.•Less frequently microneurography has also been used to show abnormal nociceptor outflow in peripheral nervous system disorders.
    Clinical Neurophysiology 10/2014; 126(3). DOI:10.1016/j.clinph.2014.10.009 · 2.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Autonomic dysfunction is often a late feature of multiple system atrophy (MSA). Based on early features, MSAp (Parkinsonian) and MSAc (cerebellar) variants are known. We studied the severity of autonomic dysfunction at first examination in MSA patient that may have relevance in its early diagnosis.
    Clinical Neurology and Neurosurgery 03/2015; 130. DOI:10.1016/j.clineuro.2014.09.018 · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Multiple system atrophy (MSA) is an α-synucleinopathy that is clinically characterized by varying degrees of parkinsonian, autonomic, and cerebellar features. Unlike other α-synucleinopathies such as Parkinson's disease, MSA is unique in that the principal α-synuclein lesions, called glial cytoplasmic inclusions, occur in oligodendroglia rather than neurons, with significantly more α-synuclein accumulating in MSA brain compared with Parkinson's disease. Although well defined clinically, the molecular pathophysiology of MSA has barely been investigated. In particular, there have been no systematic studies of the perturbation of the brain transcriptome during the onset and progression of this disease. Interestingly, measurements of α-synuclein gene (SNCA) expression in MSA brain tissue have not revealed overexpression of this gene in oligodendroglia or neurons. It has therefore become clear that other genes and gene networks, both directly as noncoding RNAs or through protein products, contribute to the accumulation of the α-synuclein protein in the brain. This review provides a summary of current developments in the investigation of the transcriptional causes of MSA and outlines perspectives for future research toward the elucidation of the molecular pathology of MSA-specific neurodegeneration.
    Neurobiology of Aging 08/2014; DOI:10.1016/j.neurobiolaging.2014.08.015 · 4.85 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014